《Cancers》雜志的最新年發文量為5643篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章,以保持其在腫瘤學領域的學術影響力。
該刊聚焦于醫學-腫瘤學領域的前沿研究,致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為約18.07天 11 Weeks 。
Cancers 雜志發文統計
文章名稱引用次數
- Flavonoids in Cancer and Apoptosis72
- Gut Microbiota and Cancer: From Pathogenesis to Therapy65
- Epigenetic Modifications as Biomarkers of Tumor Development, Therapy Response, and Recurrence across the Cancer Care Continuum63
- mTOR Pathways in Cancer and Autophagy62
- Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems54
- Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells52
- New Insights into Long Non-Coding RNA MALAT1 in Cancer and Metastasis43
- Systemic Therapy for Hepatocellular Carcinoma: Latest Advances42
- Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment42
- The Extracellular Matrix and Pancreatic Cancer: A Complex Relationship41
國家/地區發文量
- USA1602
- Italy1109
- GERMANY (FED REP GER)834
- France529
- Spain433
- Japan395
- England390
- South Korea370
- Taiwan307
- Netherlands302